NL8921262A - Neutrofiel-activerend peptide-2, werkwijzen voor het bereiden van deze factor en preparaten die dit peptide bevatten. - Google Patents

Neutrofiel-activerend peptide-2, werkwijzen voor het bereiden van deze factor en preparaten die dit peptide bevatten. Download PDF

Info

Publication number
NL8921262A
NL8921262A NL8921262A NL8921262A NL8921262A NL 8921262 A NL8921262 A NL 8921262A NL 8921262 A NL8921262 A NL 8921262A NL 8921262 A NL8921262 A NL 8921262A NL 8921262 A NL8921262 A NL 8921262A
Authority
NL
Netherlands
Prior art keywords
leu
nap
fragment
lys
ala
Prior art date
Application number
NL8921262A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828728A external-priority patent/GB8828728D0/en
Priority claimed from GB898909681A external-priority patent/GB8909681D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8921262A publication Critical patent/NL8921262A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8921262A 1988-12-08 1989-11-17 Neutrofiel-activerend peptide-2, werkwijzen voor het bereiden van deze factor en preparaten die dit peptide bevatten. NL8921262A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888828728A GB8828728D0 (en) 1988-12-08 1988-12-08 Neutrophil-stimulating activity i
GB8828728 1988-12-08
GB898909681A GB8909681D0 (en) 1989-04-27 1989-04-27 Neutrophil-stimulating activity 1
GB8909681 1989-04-27

Publications (1)

Publication Number Publication Date
NL8921262A true NL8921262A (nl) 1990-11-01

Family

ID=26294713

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8921262A NL8921262A (nl) 1988-12-08 1989-11-17 Neutrofiel-activerend peptide-2, werkwijzen voor het bereiden van deze factor en preparaten die dit peptide bevatten.

Country Status (19)

Country Link
US (1) US5759533A (hu)
JP (1) JP3051160B2 (hu)
KR (1) KR910700260A (hu)
AU (1) AU634508B2 (hu)
BE (1) BE1003636A4 (hu)
CA (1) CA2004685A1 (hu)
CH (1) CH681625A5 (hu)
DK (1) DK188690A (hu)
ES (1) ES2047458A6 (hu)
FI (1) FI903931A0 (hu)
FR (1) FR2640142B1 (hu)
GB (1) GB2231872B (hu)
GR (1) GR1000455B (hu)
IL (1) IL92557A0 (hu)
NL (1) NL8921262A (hu)
NZ (1) NZ231652A (hu)
PT (1) PT92509A (hu)
SE (1) SE9002589L (hu)
WO (1) WO1990006321A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２
AU7301091A (en) * 1990-02-01 1991-08-21 University Of South Florida Leukocyte-derived growth factor
US6673893B1 (en) 1990-02-01 2004-01-06 University Of South Florida Leukocyte derived growth factor 2
AU2348492A (en) * 1991-07-19 1993-02-23 East Carolina University Method of treating asthma
WO1993009794A1 (en) * 1991-11-15 1993-05-27 University Of Pennsylvania Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
JPH08506013A (ja) * 1993-01-07 1996-07-02 ユニバーシテイ・オブ・サウス・フロリダ 白血球由来成長因子
US5578569A (en) * 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
EP1015486A2 (en) * 1997-09-25 2000-07-05 Academisch Ziekenhuis bij de Universiteit van Amsterdam Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
AU785104B2 (en) 2000-03-07 2006-09-14 Japan Tobacco Inc. Polypeptides having activity of stimulating neutrophils
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
US7375192B2 (en) 2002-05-01 2008-05-20 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US7177246B2 (en) * 2003-09-12 2007-02-13 Hewlett-Packard Development Company, L.P. Optical disk drive focusing apparatus using sum signal
AU2011329647B2 (en) 2010-11-19 2015-10-22 Eisai R&D Management Co., Ltd. Neutralizing anti-CCL20 antibodies
KR101993316B1 (ko) * 2017-04-11 2019-06-26 나민자 강아지 배변기
KR102453406B1 (ko) 2020-08-24 2022-10-11 연세흠 반려동물 배변수거기

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐２

Also Published As

Publication number Publication date
GB2231872B (en) 1992-07-22
ES2047458A6 (es) 1994-02-16
CH681625A5 (hu) 1993-04-30
DK188690D0 (da) 1990-08-07
JP3051160B2 (ja) 2000-06-12
IL92557A0 (en) 1990-08-31
SE9002589D0 (sv) 1990-08-07
GR1000455B (el) 1992-07-30
SE9002589L (sv) 1990-08-07
WO1990006321A1 (en) 1990-06-14
PT92509A (pt) 1990-06-29
US5759533A (en) 1998-06-02
KR910700260A (ko) 1991-03-14
DK188690A (da) 1990-08-07
BE1003636A4 (fr) 1992-05-12
FR2640142A1 (fr) 1990-06-15
FI903931A0 (fi) 1990-08-08
GR890100810A (en) 1991-03-15
GB9011468D0 (en) 1990-08-29
NZ231652A (en) 1993-02-25
CA2004685A1 (en) 1990-06-08
GB2231872A (en) 1990-11-28
AU4655689A (en) 1990-06-26
AU634508B2 (en) 1993-02-25
FR2640142B1 (fr) 1994-09-23
JPH03503767A (ja) 1991-08-22

Similar Documents

Publication Publication Date Title
NL8921262A (nl) Neutrofiel-activerend peptide-2, werkwijzen voor het bereiden van deze factor en preparaten die dit peptide bevatten.
Bozic et al. Expression and biologic characterization of the murine chemokine KC.
Wuyts et al. Isolation of the CXC chemokines ENA‐78, GROα and GROγ from tumor cells and leukocytes reveals NH2‐terminal heterogeneity: Functional comparison of different natural isoforms
US5591718A (en) Neutrophil activating factors
US5641867A (en) Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US7338653B2 (en) Amino-terminally truncated MCP-2 as chemokine antagonists
US20070270329A1 (en) Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof
Wenger et al. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library
US5591427A (en) Human Interleukin-3(Il-3) variants and their use to promote or antagonize IL-3-mediated processes
EP0760849A1 (en) Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
WO1991008231A1 (en) [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
KR100837898B1 (ko) 다발성 경화증의 치료에서 사용되는 케모킨 변이체
WO1998006751A9 (en) Mcp-3, rantes and mip-1alpha receptor antagonists
EP0550506B1 (en) Novel chemotactic factor
KR0150000B1 (ko) 사람 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현 벡터, 형질전환 세포 및 사람 macif 활성을 갖는 단백질
IT8922620A1 (it) Peptide-2 che attiva i neutrofili
AU652575B2 (en) Novel chemotactic factor
Ehlert et al. Receptor Binding and Degranulation Activity of the Neutrophil-activating Peptide 2 (NAP-2)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: THEODOR KOCHER INSTITUT;NOVARTIS AG

BV The patent application has lapsed